# Bicara Therapeutics Inc. Common Stock (BCAX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BCAX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -111.65M | $ -81.83M | $ 1.16M | $ 468.77M |
| 2025 | $ 0 | $ -141.25M | $ -109.68M | $ 1.71M | $ 401.45M |
| 2024 | $ 0 | $ -71.47M | $ -78.64M | $ 738.0K | $ 491.88M |
| 2023 | $ 0 | $ -56.21M | $ -49.97M | $ 657.0K | $ 218.51M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.09 |
| Current Ratio | 11.59 |

## Other views

- [Metrics](https://sponda.capital/en/BCAX.md)
- [Charts](https://sponda.capital/en/BCAX/charts.md)
- [Compare](https://sponda.capital/en/BCAX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.